Christian P Larsen

USPTO Granted Patents = 6 (Patent Applications = 7)

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 4.1

ph-index = 4

Forward Citations = 170(Granted Patents)

Company Filing History:

Bristol-Myers Squibb Compnay

patents

2 out of 517

Beth Israel Deaconess Medical Center, Inc.

patents

where one patent can have more than one assignee

Years Active: 1999-2020

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10561728 - Polynucleotides encoding anti-CD40 antibodies (2020-02-18),

2. 9987356 - Anti-CD40 antibodies and methods of administering thereof (2018-06-05),

3. 8840899 - Use of mTOR inhibitors to enhance T cell immune responses (2014-09-23),

4. 7829534 - Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules (2010-11-09),

5. 7304033 - Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules (2007-12-04),

6. 5916560 - Methods for inhibiting an immune response by blocking the GP39/CD40 and (1999-06-29),

Title: Christian P. Larsen: Innovator in Antibody Development

Introduction

Christian P. Larsen is a prominent inventor based in Atlanta, GA. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of 6 patents to his name, Larsen's work focuses on innovative solutions for medical challenges.

Latest Patents

Larsen's latest patents include groundbreaking inventions related to polynucleotides encoding anti-CD40 antibodies. These inventions pertain to antibodies that are specific for a particular epitope on CD40, which have unique functional characteristics. The patents also cover fragments of these antibodies and their applications in reducing or treating transplant rejection and graft-versus-host disease. Additionally, he has developed methods for producing these antibodies, further advancing the field of immunology.

Career Highlights

Throughout his career, Christian P. Larsen has worked with esteemed organizations such as Emory University and Bristol-Myers Squibb Company. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to significant advancements in antibody research.

Collaborations

Larsen has collaborated with notable colleagues, including Peter S. Linsley and Thomas C. Pearson. These partnerships have fostered a productive environment for innovation and research in the biotechnology sector.

Conclusion

Christian P. Larsen's contributions to the field of antibody development are noteworthy. His innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to impact the treatment of critical health issues, showcasing the importance of innovation in biotechnology.

This text is generated by artificial intelligence and may not be accurate.